Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Long

Showing results (961-970 of 1,328) with videos related to

Pageof 133
Sort By:
Cancer Investigation|December 21, 2010
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donorsDavid A Rizzieri, Christopher Crout, Robert Storms, et al.
Bone Marrow Transplantation|December 6, 2011
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donorsD-F Chen, V K Prasad, G Broadwater, et al.
Cancer|May 26, 2004
Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphomaDavid A Rizzieri, Gregory J Sand, Dean McGaughey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 11, 2017
Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and HospitalizationSarah Anand, Samantha Thomas, Terry Hyslop, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2000
Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cellsK E Stockerl-Goldstein, S A Reddy, S F Horning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemiaDavid A Rizzieri, Valerie K Ibom, Joseph O Moore, et al.
Iscience|November 29, 2023
Aryl hydrocarbon receptor is a tumor promoter in <i>MYCN</i>-amplified neuroblastoma cells through suppression of differentiationKanita A Chaudhry, Justine J Jacobi, Bryan M Gillard, et al.
Cancer Immunology Research|July 1, 2024
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLsBowen Dong, Nataša Obermajer, Takemasa Tsuji, et al.
Journal of Medical Imaging (Bellingham, Wash.)|August 24, 2018
Water-fat magnetic resonance imaging quantifies relative proportions of brown and white adipose tissues: <i>ex-vivo</i> experimentsJadranka Stojanovska, Carey N Lumeng, Cameron Griffin, et al.
JMIR Research Protocols|January 7, 2016
Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility StudyRachel L Randell, Ajay S Gulati, Suzanne F Cook, et al.
Pageof 133

Showing results (961-970 of 1,328) with videos related to

Sort By:
Pageof 133
Cancer Investigation|December 21, 2010
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donorsDavid A Rizzieri, Christopher Crout, Robert Storms, et al.
Bone Marrow Transplantation|December 6, 2011
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donorsD-F Chen, V K Prasad, G Broadwater, et al.
Cancer|May 26, 2004
Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphomaDavid A Rizzieri, Gregory J Sand, Dean McGaughey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 11, 2017
Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and HospitalizationSarah Anand, Samantha Thomas, Terry Hyslop, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2000
Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cellsK E Stockerl-Goldstein, S A Reddy, S F Horning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemiaDavid A Rizzieri, Valerie K Ibom, Joseph O Moore, et al.
Iscience|November 29, 2023
Aryl hydrocarbon receptor is a tumor promoter in <i>MYCN</i>-amplified neuroblastoma cells through suppression of differentiationKanita A Chaudhry, Justine J Jacobi, Bryan M Gillard, et al.
Cancer Immunology Research|July 1, 2024
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLsBowen Dong, Nataša Obermajer, Takemasa Tsuji, et al.
Journal of Medical Imaging (Bellingham, Wash.)|August 24, 2018
Water-fat magnetic resonance imaging quantifies relative proportions of brown and white adipose tissues: <i>ex-vivo</i> experimentsJadranka Stojanovska, Carey N Lumeng, Cameron Griffin, et al.
JMIR Research Protocols|January 7, 2016
Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility StudyRachel L Randell, Ajay S Gulati, Suzanne F Cook, et al.
Pageof 133